Using this definition, 25.0% (95% CI, 16.7–34.9%) of patients with HNSCC presented with elevated Sema4D (Figure 4A) (Supplementary Table 2). The gene discussed is SEMA4D; the disease is head and neck squamous cell carcinoma.